MADRID, July 31, 2018 /PRNewswire/ -- ATLANTIS study, in small-cell lung cancer with lurbinectedin, recruited 600 patients in a total of 160 hospital centers in 20 countries Top line data is expected to readout around the end of 2019 PharmaMar (M...
from PR Newswire: //https://ift.tt/2LRkRpd
No comments:
Post a Comment